Problems for the chemotherapy of human African trypanosomiasis

Current Opinion in Infectious Diseases

Volumn 13, Issue 6, 2000, Pages 647-651

  Barrett, Michael P ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 (1 METHYL 5 NITRO 2 IMIDAZOLYL) 1,3,4 THIADIAZOLE; ANTITRYPANOSOMAL AGENT; EFLORNITHINE; ETHIDIUM; ISOMETAMIDIUM; MELARSOPROL; NIFURTIMOX; PENTAMIDINE; SURAMIN;

AFRICAN TRYPANOSOMIASIS; BLOOD BRAIN BARRIER; BRAIN DISEASE; CEREBROSPINAL FLUID; COMBINATION CHEMOTHERAPY; DRUG COST; DRUG MECHANISM; DRUG SENSITIVITY; DRUG TARGETING; HUMAN; NONHUMAN; REVIEW; TRYPANOSOMA;

EID: 0033663030     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200012000-00012     Document Type: Review

References (42)

1. The fall and rise of sleeping sickness
2. Human African trypanosomiasis: An emerging public health crisis
3. Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia
4. An automated biological assay to determine levels of the trypanocidal drug melarsoprol in biological fluids
5. Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: A randomised trial
6. 2 binding sites
7. Suramin treatment in hormone- and chemotherapy-refractory prostate cancer
8. Pharmacology of cloned P2x receptors
9. Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model
10. Drug resistance in African trypanosomes
11. Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda
12. Arsenical-resistant trypanosomes lack an unusual adenosine transporter
13. A nucleoside transporter from Trypanosoma brucei involved in drug resistance
14. The biochemical basis of cross-resistance between arsenicals and diamidines in African trypanosomes
15. Drug management and parasite resistance in bovine trypanosomiasis in Africa
16. Sleeping sickness
17. Multicentre evaluation of the card indirect agglutination test for trypanosomiasis (TrypTect CIATT(R))
18. Investigations of the metabolites of the trypanocidal drug melarsoprol
19. Physico-chemical properties of the trypanocidal drug melarsoprol
20. Prodrugs for amidines: Synthesis and anti-Pneumocystis carinii activity of carbamates of 2,5-Bis(4-amidinophenyl)furan
21. Synthesis and anti-Pneumocystis carinii pneumonia activity of novel dicationic dibenzothiophenes and orally active prodrugs
22. Co-operative binding sites for transported substrates in the multiple drug resistance transporter Mdr1
23. Pharmacokinetics, metabolism and excretion of megazol in Trypanosoma brucei gambiense primate model of human African trypanosomiasis
24. Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (TM) (RMP-7): Dramatic differences and insight gained from dosing parameters
25. Zaire (Congo): Resurgence of trypanosomiasis ('patients within borders')
26. Combination chemotherapy of CNS trypanosomiasis
27. High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness - An open trial in central Zaire
28. A seven days course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness
29. Genomics and the biology of parasites
30. Recent advances in identifying and validating drug targets in trypanosomes and leishmania
31. Parallel synthesis of a library of 1,4-naphthoquinones and automated screening of potential inhibitors of trypanothione reductase from Trypanosoma cruzi
32. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase
33. Adenosine transporters in bloodstream forms of Trypanosoma brucei brucei: Substrate recognition motifs and affinity for trypanocidal drugs
34. The in vitro trypanocidal activity of organotin compounds
35. An approach to use an unusual adenosine transporter to selectively deliver polyamine analogues to trypanosomes
36. Synthesis and uptake of nitric oxide-releasing drugs by the P2 nucleoside transporter in Trypanosoma equiperdum
37. Antitrypanosomal activity of a new triazine derivative, SIPI 1029, in vitro and in model infections
38. In vitro and in vivo activities of trybizine hydrochloride against various pathogenic trypanosome species
39. In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors
40. Uptake of the nitroimidazole drug megazol by African trypanosomes
41. Is orphan drug status beneficial to tropical disease control? Comparison of the American and future European orphan drug acts
42. Access to essential drugs in poor countries - A lost battle?